Translating Cell and Gene Biopharmaceutical Products for Health and Market Impact. Product Scaling From Clinical to Marketplace: Lessons Learned and Future Outlook.

Bak, Annette; Friis, Kristina Pagh; Wu, Yan; Ho, Rodney J Y

Bak, Annette; Friis, Kristina Pagh; Wu, Yan; Ho, Rodney J Y.

Afiliação

Bak A; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: annette.bak@astrazeneca.com.
Friis KP; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Wu Y; Department of Pharmacy, Air Force Medical Center of PLA, Beijing 100142, China; Departments of Pharmaceutics and Bioengineering, University of Washington, Seattle, Washington 98195-357610.
Ho RJY; Departments of Pharmaceutics and Bioengineering, University of Washington, Seattle, Washington 98195-357610; Clinical Pharmacology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109.

J Pharm Sci ; 108(10): 3169-3175, 2019 10.

Article em En | MEDLINE | ID: mdl-31150697

Assuntos

Produtos Biológicos/química; Terapia Baseada em Transplante de Células e Tecidos/métodos; Edição de Genes/métodos; Terapia Genética/métodos; Vetores Genéticos/genética; Humanos

Palavras-chave

biotechnology; cell culture; distribution; drug design; formulation; gene delivery; gene therapy; gene vector(s); nanotechnology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos Limite: Humans Idioma: En Revista: J Pharm Sci Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google